Form D · Manufacturing
AiTA Bio Inc.
New York, NY · CIK 0002051873
Offering snapshot reported Jan 14, 2025 · SEC filing
- Reported sold
- $10M Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $5M Reported outside-investor minimum
- First sale
- Jan 13, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 14, 2025 | Initial | $10,000,009 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-535067
Source: Form D, filed Jan 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dilan Casanovas | Director, Executive |
| Jacob Menture | Director, Executive, Promoter |
Issuer details
Industry: Manufacturing (See others in industry)
Address:
139 5 Th Avenue Floor 5
New York, NY, 10010
New York, NY, 10010